Preoperative Weight Loss Intervention With Glucagon-Like Peptides 1 Receptor Agonists Is Associated With Lower Complication Rates Following Primary Total Knee Arthroplasty Than Preoperative Bariatric Surgery
George Bcharah, Austin E. Wininger, Zaid Elsabbagh, Collin L. Braithwaite, Paul R. Van Schuyver, Mark J. Spangehl, Henry D. Clarke, Joshua S. Bingham · 2026
Read Preoperative Weight Loss Intervention With Glucagon-Like Peptides 1 Receptor Agonists Is Associated With Lower Complication Rates Following Primary Total Knee Arthroplasty Than Preoperative Bariatric Surgery by George Bcharah, Austin E. Wininger, Zaid Elsabbagh, Collin L. Braithwaite, Paul R. Van Schuyver, Mark J. Spangehl, Henry D. Clarke, Joshua S. Bingham (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13206731.txt.
Description
Heavy weight raises the risk of a new knee joint, and two roads can slim a patient first: gut cut or shot drugs that curb the gut's call. George Bcharah and co-authors weigh the roads in a 2026 chart sweep. They match like patients in three sets: gut cut, drug, or no slim step in the year past.
The gut cut set fared worst: joint germ ills and full do overs ran high next to the drug set, in near twice the odds. Next to the no step set, the cut set also drew more joint ills and bone breaks. The drug set drew less ill than the no step set at most marks and weights. The team backs the drugs as the safer first road.
Catalog record
| CREATOR | George Bcharah, Austin E. Wininger, Zaid Elsabbagh, Collin L. Braithwaite, Paul R. Van Schuyver, Mark J. Spangehl, Henry D. Clarke, Joshua S. Bingham |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |